Who We Are
Pre-IPO company currently offering shares in the fund at $0.48 per share.
REG A+ offering allows both accredited and non-accredited investors to participate in Pre-IPO companies for the first time.
Fund intends to up-list onto a Public Exchange in the fall of 2018.
Focused on acquiring revenue generating companies in the fast growing cannabis and hemp industries and ancillary products and services.
Partnered with industry leading professionals, companies and innovative technologies.
We are looking to the future
Green Leaf is focused on high quality large-scale GMP certified production of pharmaceutical grade cannabis and CBD products at the lowest production costs for export to high-cost, high-margin countries such as Canada, Germany and Italy.
Green Leaf Investment Fund, Inc. is a holdings company, based in the United States, acquiring cannabis licensed producers and innovative ancillary technology products and services in federally legal countries across the globe.